Gasbarrini G, Andreone P, Baraldini M, Bonvicini F, Cursaro C, Brocchi E
Department of Internal Medicine, University of Bologna, Italy.
Int J Clin Pharmacol Res. 1990;10(3):173-8.
Experiments performed in animals and in healthy human subjects suggest that antacids increase prostaglandin synthesis and have a cytoprotective effect on gastroduodenal mucosa. To investigate this hypothesis, the ability was evaluated of an antacid containing an aluminium/magnesium hydroxide combination (Maalox TC) to modify prostanoid production at the gastric level in 28 patients with gastric antral ulcer of various sizes in different stages of activity with or without erosive gastritis. After the antacid treatment, a significant prostaglandin E2 reduction was observed, together with a significant 6-keto-prostaglandin F1 alpha increase, but there was no thromboxane B2 variation at antrum level, nor any significant modification of prostanoid production at body level. The decreased prostaglandin E2 levels, detected after treatment with the antacid combination, may be due to lesion improvement, decreased synthesis or increased catabolism by mucosal cells, to a drop in this prostaglandin production by inflammatory cells. As far as 6-keto-prostaglandin F1 alpha is concerned, the obtained data confirm the results reported by other authors in healthy human subjects. The increase of this prostaglandin could enhance blood flow, resulting in a protective effect.
在动物和健康人体受试者身上进行的实验表明,抗酸剂可增加前列腺素的合成,并对胃十二指肠黏膜具有细胞保护作用。为了研究这一假设,我们评估了一种含有氢氧化铝/氢氧化镁组合(Maalox TC)的抗酸剂对28例处于不同活动阶段、伴有或不伴有糜烂性胃炎的各种大小胃窦溃疡患者胃内前列腺素生成的影响。抗酸剂治疗后,观察到前列腺素E2显著降低,同时6-酮-前列腺素F1α显著增加,但胃窦水平的血栓素B2没有变化,胃体水平的前列腺素生成也没有任何显著改变。抗酸剂组合治疗后检测到的前列腺素E2水平降低,可能是由于病变改善、合成减少或黏膜细胞分解代谢增加,也可能是炎症细胞产生的这种前列腺素减少。就6-酮-前列腺素F1α而言,所得数据证实了其他作者在健康人体受试者中报道的结果。这种前列腺素的增加可能会增强血流量,从而产生保护作用。